SIRS-Lab Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
34
- Latest Deal Type
-
M&A
SIRS-Lab General Information
Description
Developer of diagnostic technology intended to treat infections. The company specializes in detecting blood poisoning and sepsis and causative agent while monitoring specific immune responses for treatment information.
Contact Information
Website
sirslab.comCorporate Office
- Otto-Schott-Straße 15
- 07745 Jena
- Germany
Corporate Office
- Otto-Schott-Straße 15
- 07745 Jena
- Germany
SIRS-Lab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 06-May-2013 | Completed | Bankruptcy: Admin/Reorg | |||
| 3. Bankruptcy: Admin/Reorg | 01-Jan-2013 | Completed | Bankruptcy: Admin/Reorg | |||
| 2. Later Stage VC (Series A) | 14-Dec-2006 | $13.1M | $13.1M | Completed | Product Development | |
| 1. Early Stage VC | Completed | Product Development |
SIRS-Lab Patents
SIRS-Lab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102011005235-A1 | A method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for in vitro determination of a severity of the host response of a patient | Active | 08-Mar-2011 | ||
| DE-102011005235-B4 | A method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for in vitro determination of a severity of the host response of a patient | Inactive | 08-Mar-2011 | ||
| WO-2012120026-A1 | Method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for the in vitro determination of the severity of the host response of a patient | Inactive | 08-Mar-2011 | ||
| DE-102009044085-A1 | Method for in vitro detection and differentiation of pathophysiological conditions | Inactive | 23-Sep-2009 | ||
| US-20110076685-A1 | Method for in vitro detection and differentiation of pathophysiological conditions | Inactive | 23-Sep-2009 | C12Q1/6883 |
SIRS-Lab Signals
SIRS-Lab Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Affentranger Associates | Venture Capital | Minority | ||
| bm-t Beteiligungsmanagement Thuringen | Growth/Expansion | Minority |
SIRS-Lab FAQs
-
When was SIRS-Lab founded?
SIRS-Lab was founded in 2000.
-
Where is SIRS-Lab headquartered?
SIRS-Lab is headquartered in Jena, Germany.
-
What is the size of SIRS-Lab?
SIRS-Lab has 34 total employees.
-
What industry is SIRS-Lab in?
SIRS-Lab’s primary industry is Diagnostic Equipment.
-
Is SIRS-Lab a private or public company?
SIRS-Lab is a Private company.
-
What is SIRS-Lab’s current revenue?
The current revenue for SIRS-Lab is .
-
How much funding has SIRS-Lab raised over time?
SIRS-Lab has raised $13.1M.
-
Who are SIRS-Lab’s investors?
Affentranger Associates and bm-t Beteiligungsmanagement Thuringen have invested in SIRS-Lab.
-
When was SIRS-Lab acquired?
SIRS-Lab was acquired on 06-May-2013.
-
Who acquired SIRS-Lab?
SIRS-Lab was acquired by Analytik Jena.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process